- Home
- NRIM vs HUMA Comparison
NRIM vs HUMA Comparison
Compare NRIM & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- HUMA
- Stock Information
- Founded
- NRIM 1990
- HUMA 2004
- Country
- NRIM United States
- HUMA United States
- Employees
- NRIM N/A
- HUMA N/A
- Industry
- NRIM Savings Institutions
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- HUMA Health Care
- Exchange
- NRIM Nasdaq
- HUMA Nasdaq
- Market Cap
- NRIM 463.5M
- HUMA 503.1M
- IPO Year
- NRIM N/A
- HUMA N/A
- Fundamental
- Price
- NRIM $81.21
- HUMA $3.54
- Analyst Decision
- NRIM
- HUMA Strong Buy
- Analyst Count
- NRIM 0
- HUMA 7
- Target Price
- NRIM N/A
- HUMA $13.43
- AVG Volume (30 Days)
- NRIM 56.3K
- HUMA 1.5M
- Earning Date
- NRIM 01-24-2025
- HUMA 03-21-2025
- Dividend Yield
- NRIM 2.98%
- HUMA N/A
- EPS Growth
- NRIM 47.44
- HUMA N/A
- EPS
- NRIM 6.62
- HUMA N/A
- Revenue
- NRIM $151,931,000.00
- HUMA N/A
- Revenue This Year
- NRIM N/A
- HUMA N/A
- Revenue Next Year
- NRIM $6.61
- HUMA $4,344.68
- P/E Ratio
- NRIM $12.64
- HUMA N/A
- Revenue Growth
- NRIM 20.78
- HUMA N/A
- 52 Week Low
- NRIM $43.92
- HUMA $2.81
- 52 Week High
- NRIM $91.72
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- NRIM 43.02
- HUMA 29.77
- Support Level
- NRIM $81.65
- HUMA $3.70
- Resistance Level
- NRIM $88.57
- HUMA $4.14
- Average True Range (ATR)
- NRIM 2.98
- HUMA 0.22
- MACD
- NRIM -0.83
- HUMA -0.06
- Stochastic Oscillator
- NRIM 7.89
- HUMA 0.00
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.